| Useful Advices |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Ethics > No More Gold Watches |
|
Useful Advices - No More Gold Watches
When people from my grandfather’s generation retired after being with a company for decades they got gold watches. Gold watches no According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product longer exist as far as companies are concerned. Now companies give out pink slips (a.k.a. their walking papers) after 25 years of s ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in rvice. We are living in a different world but it is humorous to me in a way. Companies no longer have loyalty to those employees t lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. at have been loyal to them for years and years of service. When it is clear that companies no longer care about their employees in here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe ost cases, it is funny to me when the management of a company gets upset when the employees are no longer loyal to them either. The d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro y still expect the employees to be loyal without giving it in return. The same applies for customers. They get upset when a custom ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc r of 25 years leaves for a company just because of a cheaper price. I have said in a previous article that I work for Liberty Mutua easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi Insurance. Since I have gotten in the department I am in now, which is Personal Sales, I have seen some very good employees either nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically forced out the door or forced into taking demotions. The new management comes in and decides they want their own people in place. and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ They either eliminate positions to get some people out the door or they just “performance manage” them out the door. I am not singl ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi ng out Liberty Mutual by any means. In fact, I suspect other companies are even worse because Liberty has historically been a very ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a onservative company. Other more aggressive companies are probably laying even more people off, or pushing more people out the doors dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod so they can replace them with “their” people who are younger and cheaper. I am also not saying that some of the older people do not cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin deserve to move on. Some people I have managed over the last year and a half in this department just do not want to be here and th tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen y make it obvious. They continue to do things the way they have always done it. They make little effort to learn new technologies t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel nd procedures to keep up with the changing business world and customer’s demands. These people are not the ones I am referring to i ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust this article. I am referring to the people who are on top of their game, still making a significant contribution to the company an y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products d they are just forced out because management does not like them. I think Liberty Mutual is one of the last companies that still ha . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de a large population of employees who have worked their whole career for the company. I also think this is not going to be the case elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip ive or ten years down the road. It is a shame that business has become so ruthless and does not care about the employees any longer tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:All the Different Kinds and Types of Nursing Jobs Questions to Ask Yourself about Incentive and Rebates
|